Drugs / Inactive SARS-CoV-2 vaccine (Vero cell)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04892459 Comparator | May → Jul 2021 | COVID-19 | Jiangsu Province Centers for Disease Control and Prevention | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactive SARS-CoV-2 vaccine (Vero cell) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04892459 ↗ |
| Modality | Vaccine | “inactivated COVID-19 vaccine(CoronaVac)” PMID 42464341 ↗ Jul 2026 |